Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2026-04-05 @ 3:25 AM
Study NCT ID:
NCT03182166
Status:
COMPLETED
Last Update Posted:
2022-03-14
First Post:
2017-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-29
First Submit QC Date:
None
Study First Post Date:
2017-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-11
Last Update Post Date:
2022-03-14
Last Update Post Date Type:
ACTUAL